Is Haemonetics Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Haemonetics Corp (HAE) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Haemonetics Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Haemonetics Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Haemonetics Corp?

Muslim investors may consider investing in Haemonetics Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Haemonetics Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Haemonetics Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Haemonetics Corp updated?

The Shariah compliance status of Haemonetics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Haemonetics Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Haemonetics Corp?

You can check the latest Shariah compliance status of Haemonetics Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

HAE Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 10, 2026

Report Source: 2026 3rd Quarter Report

Haemonetics Corp. Stock Analysis HAE

United States Health Care Mid Cap Report: Q3, 2026

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). The company also offers solutions for structural heart and endovascular procedures.

Key Statistics of Haemonetics Corp (HAE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$56.26$58.18

Today's Open

$57.27

Volume

911.91K

P/E Ratio (TTM)

15.60

52 Week Range

$47.32$87.32

Market Cap

2.58B

Avg. Volume

855.99K

Dividend Yield

Financial Metrics & Statements of Haemonetics Corp (HAE)

FAQ's for Haemonetics Corp (HAE)

According to Musaffa’s Shariah screening methodology, Haemonetics Corp (HAE) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.